These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5369 related articles for article (PubMed ID: 3942687)

  • 61. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth.
    Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY
    J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Momilactione B inhibits protein kinase A signaling and reduces tyrosinase-related proteins 1 and 2 expression in melanocytes.
    Lee JH; Cho B; Jun HJ; Seo WD; Kim DW; Cho KJ; Lee SJ
    Biotechnol Lett; 2012 May; 34(5):805-12. PubMed ID: 22215377
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cosmetic applications of glucitol-core containing gallotannins from a proprietary phenolic-enriched red maple (Acer rubrum) leaves extract: inhibition of melanogenesis via down-regulation of tyrosinase and melanogenic gene expression in B16F10 melanoma cells.
    Ma H; Xu J; DaSilva NA; Wang L; Wei Z; Guo L; Johnson SL; Lu W; Xu J; Gu Q; Seeram NP
    Arch Dermatol Res; 2017 May; 309(4):265-274. PubMed ID: 28283753
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Astaxanthin and withaferin A block paracrine cytokine interactions between UVB-exposed human keratinocytes and human melanocytes via the attenuation of endothelin-1 secretion and its downstream intracellular signaling.
    Niwano T; Terazawa S; Nakajima H; Wakabayashi Y; Imokawa G
    Cytokine; 2015 Jun; 73(2):184-97. PubMed ID: 25777483
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acanthoic acid inhibits melanogenesis through tyrosinase downregulation and melanogenic gene expression in B16 melanoma cells.
    Yoon WJ; Ham YM; Yoon HS; Lee WJ; Lee NH; Hyun CG
    Nat Prod Commun; 2013 Oct; 8(10):1359-62. PubMed ID: 24354173
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-melanogenic effects of Aster spathulifolius extract in UVB-exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling.
    Hwang GY; Choung SY
    J Pharm Pharmacol; 2016 Apr; 68(4):503-13. PubMed ID: 26993057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
    Tatzel J; Poser I; Schroeder J; Bosserhoff AK
    Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibitory effect of a novel combination of Salvia hispanica (chia) seed and Punica granatum (pomegranate) fruit extracts on melanin production.
    Diwakar G; Rana J; Saito L; Vredeveld D; Zemaitis D; Scholten J
    Fitoterapia; 2014 Sep; 97():164-71. PubMed ID: 24909999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The ultrastructure of conjunctival melanocytic tumors.
    Jakobiec FA
    Trans Am Ophthalmol Soc; 1984; 82():599-752. PubMed ID: 6398936
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma.
    Borovanský J; Mirejovský P; Riley PA
    Neoplasma; 1991; 38(4):393-400. PubMed ID: 1922572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
    Vad NM; Yount G; Moridani MY
    Melanoma Res; 2008 Dec; 18(6):386-99. PubMed ID: 18971789
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autophagy mediates anti-melanogenic activity of 3'-ODI in B16F1 melanoma cells.
    Kim ES; Shin JH; Seok SH; Kim JB; Chang H; Park SJ; Jo YK; Choi ES; Park JS; Yeom MH; Lim CS; Cho DH
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):165-70. PubMed ID: 24269817
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The biphasic nature of a human amelanotic melanoma tumour line HT-18.
    Iyengar B; Tímár J; Szende B
    Acta Morphol Hung; 1988; 36(3-4):235-40. PubMed ID: 3151541
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dielectrophoresis of malignant human melanocytes.
    Mischel M; Rougé F; Lamprecht I; Aubert C; Prota G
    Arch Dermatol Res; 1983; 275(3):141-3. PubMed ID: 6614991
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Normal uveal melanocytes in culture.
    Hu F; Teramura DJ; Mah K
    Pigment Cell Res; 1987; 1(2):94-103. PubMed ID: 3507670
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.
    Wick MM
    J Invest Dermatol; 1989 May; 92(5 Suppl):329S-331S. PubMed ID: 2715667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biochemical studies of a protein which restores contact inhibition of growth to malignant melanocytes.
    Knecht ME; Lipkin G
    Exp Cell Res; 1977 Aug; 108(1):15-22. PubMed ID: 196868
    [No Abstract]   [Full Text] [Related]  

  • 78. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary malignant melanoma of the bronchus.
    Adebonojo SA; Grillo IA; Durodola JI
    J Natl Med Assoc; 1979 Jun; 71(6):579-81. PubMed ID: 480395
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Complex therapy of melanoma metastases in the lung].
    Nivinskaia MM; Iavorskiĭ VV; Musatov VK; Ogurtsova IN
    Med Radiol (Mosk); 1984 Feb; 29(2):7-10. PubMed ID: 6700393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 269.